Sagent Pharmaceuticals launches oxaliplatin

8/9/2012

SCHAUMBURG, Ill. — Drug maker Sagent Pharmaceuticals has launched a generic chemotherapy drug, the company said Thursday.



Sagent announced the launch of oxaliplatin, a generic version of Sanofi's Eloxatin.



Various versions of the drug had sales of about $1.7 billion during the 12-month period ended in June, according to IMS Health.




Interested in this topic? Sign up for our weekly DSN Collaborative Care e-newsletter.

X
This ad will auto-close in 10 seconds